Please Wait...

Ira Goodman

Translation skills

Main profile

Ira Goodman
Ira Goodman, MD
Key Opinion Leader

A board certified neurologist specializing in Alzheimer's disease, Parkinson's disease, dementia, and other neurodegenerative disorders, Dr. Goodman has worked on over 100 clinical trials. His investigations have covered all phases of clinical research and are highlighted by numerous groundbreaking trials in Alzheimer's disease. He is extensively published in the field of neurology, most particularly in the area of biomarkers in Alzheimer's disease.

In addition to his work as a Principal Investigator, Dr. Goodman serves as the Medical Director of the Compass Clinic, a private neurology practice within the Bioclinica Research Network.

He currently serves as an Associate Professor of Neurology at the University of Central Florida, College of Medicine and as an Associate Clinical Professor of Neurology at the University of Florida, College of Medicine.

Before joining the Bioclinica Research Network, Dr. Goodman led neurology at Orlando Regional Medical Center and founded the state-funded Memory Disorder Center of Central Florida, where he has served as director for the past 15 years.

Dr. Goodman has been named "Top Neurologist in Central Florida" for 14 consecutive years by Orlando Magazine, was named "Top Neurologist in the Country" by US News & World Report, and is sought after and quoted by The Wall Street Journal as a leading authority on Alzheimer's disease.

Dr. Goodman earned his medical degree at the Medical College of Pennsylvania.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Today at #SCDM2018 be sure to catch the Technology Ignite session @SCDM_DataDriven where @bioclinica's Clean Patien… https://t.co/HPs0hrLWwO
bioclinica (3 hours ago)
RT @eClinical_Jen: Data Management times are a’changing! AI, Machine Learning, Blockchain, IoT. Leadership Forum at @SCDM_DataDriven #scdm2…
bioclinica (3 hours ago)
RT @virtue_insight: #VIphv We are delighted to announce our new Gold Sponsor @bioclinica for our 16th Pharmacovigilance 2018 https://t.co/h…
bioclinica (5 days ago)
RT @bioclinica: Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas R embra…
bioclinica (5 days ago)
Tackling the costly issue of drug supply waste in clinical trials. Find out how Novo Nordisk & other global pharmas… https://t.co/iW7Q9DfVgQ
bioclinica (2 weeks ago)
Background & key considerations to help #pharma prepare for new FDA blood pressure draft guidance issued in May. Ac… https://t.co/07dJeeD35E
bioclinica (3 weeks ago)

Latest Blogs:

Blood pressure monitor
Prescription box
Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations